CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
COO Jeff E. Knight sold $370K of Crinetics Pharmaceuticals, Inc.
Sold$370,411
$37.37Price
9,911Shares
−8%Stake
What CRNX did after the filing
- The stock from Thu, Mar 19 open, $35.70
- +9.3%
- S&P 500, same days
- +9.7%
Measured over 30 trading days, to the May 1 close.
Traded Mon, Mar 16. Filed Wed, Mar 18, 5:13 PM ET, after the close. Returns use the Mar 19 open and the May 1 close. Not investment advice.